Listed

Universal Health Realty Income Trust

UHTNYSECIK 798783Real estateFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$25.0mRevenue, Q2 FY2026, three months to 2026-06-30$25.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 7, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$25.0mRevenue, Q2 FY2026, three months to 2026-06-30$25.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure+0.5% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin36.8%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Revenue: $25.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure+1.3 pts on a year earlier
  • Net margin23.6%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $5.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Revenue: $25.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure+5.6 pts on a year earlier
  • Diluted EPS$0.43Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure+34.4% on a year earlier
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$25.0mOperating margin 36.8%
Diluted EPS$0.43, Q2 FY2026
Universal Health Realty Income Trust, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m24.5Revenue, Q3 FY2024, three months to 2024-09-30$24.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure24.6Revenue, Q4 FY2024, three months to 2024-12-31$24.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure24.5Revenue, Q1 FY2025, three months to 2025-03-31$24.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure24.9Revenue, Q2 FY2025, three months to 2025-06-30$24.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure25.3Revenue, Q3 FY2025, three months to 2025-09-30$25.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure24.5Revenue, Q4 FY2025, three months to 2025-12-31$24.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure24.5Revenue, Q1 FY2026, three months to 2026-03-31$24.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure25.0Revenue, Q2 FY2026, three months to 2026-06-30$25.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%34.7%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Revenue: $24.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure37.6%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Revenue: $24.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure36.8%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Revenue: $24.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure35.6%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $8.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Revenue: $24.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure33.2%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $8.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Revenue: $25.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure34.7%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Revenue: $24.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure36.5%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Revenue: $24.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure36.8%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Revenue: $25.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure
Net margin%16.3%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Revenue: $24.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure18.9%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $4.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Revenue: $24.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure19.5%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Revenue: $24.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure18.1%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Revenue: $24.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure15.9%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Revenue: $25.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure17.7%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $4.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Revenue: $24.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure20.5%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Revenue: $24.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure23.6%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $5.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Revenue: $25.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure
Diluted EPS$ per share0.29Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figurenot reported (Diluted EPS not reported)0.34Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure0.32Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure0.29Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figurenot reported (Diluted EPS not reported)0.36Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure0.43Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$99.2mOperating margin 35.0%
Diluted EPS$1.27, FY2025
Free cash flow$35.3m, FY2023
Universal Health Realty Income Trust, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m84.2Revenue, FY2021, twelve months to 2021-12-31$84.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-27, accession 0000950170-24-021191.Report this figure90.6Revenue, FY2022, twelve months to 2022-12-31$90.6m. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-26, accession 0000950170-25-027861.Report this figure95.6Revenue, FY2023, twelve months to 2023-12-31$95.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure99.0Revenue, FY2024, twelve months to 2024-12-31$99.0m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure99.2Revenue, FY2025, twelve months to 2025-12-31$99.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%34.3%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $28.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-27, accession 0000950170-24-021191.Revenue: $84.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-27, accession 0000950170-24-021191.Report this figure33.8%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $30.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-26, accession 0000950170-25-027861.Revenue: $90.6m. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-26, accession 0000950170-25-027861.Report this figure32.8%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $31.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594.Revenue: $95.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure37.2%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $36.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594.Revenue: $99.0m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure35.0%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $34.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594.Revenue: $99.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure
Net margin%129.7%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $109.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-27, accession 0000950170-24-021191.Revenue: $84.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-27, accession 0000950170-24-021191.Report this figure23.3%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $21.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-26, accession 0000950170-25-027861.Revenue: $90.6m. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-26, accession 0000950170-25-027861.Report this figure16.1%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $15.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594.Revenue: $95.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure19.4%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $19.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594.Revenue: $99.0m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure17.8%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $17.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594.Revenue: $99.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure
Diluted EPS$ per share7.92Diluted EPS, FY2021, twelve months to 2021-12-31$7.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-27, accession 0000950170-24-021191.Report this figure1.53Diluted EPS, FY2022, twelve months to 2022-12-31$1.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-26, accession 0000950170-25-027861.Report this figure1.11Diluted EPS, FY2023, twelve months to 2023-12-31$1.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure1.39Diluted EPS, FY2024, twelve months to 2024-12-31$1.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure1.27Diluted EPS, FY2025, twelve months to 2025-12-31$1.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure
Free cash flow$m34.7Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $47.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-27, accession 0000950170-24-021191.Capital expenditure: $13.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-27, accession 0000950170-24-021191.Report this figure33.2Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $46.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-26, accession 0000950170-25-027861.Capital expenditure: $13.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-26, accession 0000950170-25-027861.Report this figure35.3Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $42.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071594.Capital expenditure: $7.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figurenot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Universal Health Realty Income Trust
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$65.4m1,492,098Reduced−768,355
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$37.1m845,483Reduced−112,303
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$24.6m560,954Reduced−34,299
STATE STREET CORP2026-06-30$16.6m377,502Reduced−181,758
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$16.5m375,669Added+22,565
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.2026-06-30$15.5m353,543Added+13,413
JANE STREET GROUP, LLC2026-06-30$11.7m267,488Added+254,570
TWO SIGMA INVESTMENTS, LP2026-06-30$10.1m229,241Added+100,606
Qube Research & Technologies Ltd2026-06-30$9.1m206,730Added+75,957
CITADEL ADVISORS LLC2026-06-30$8.8m200,666Added+127,275

Recent filings

All 570 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Universal Health Realty Income Trust, recent filings
FiledFormWhat it isAccession number
2026-10-2716:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-434277
2026-08-0716:15 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-340281
2026-07-2716:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-318144
2026-06-1116:15 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001193125-26-267569
2026-05-0716:17 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-211984
2026-04-2806:30 ETDEF 14AProxy statementPeriod 2026-06-100001193125-26-183412
2026-04-2716:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-182162
2026-04-2408:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-26-175196
2026-02-2516:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-071714
2026-02-2516:16 ET10-KAnnual reportPeriod 2025-12-310001193125-26-071594

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 25, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested.See the target

About the filer

CIK
798783
Tickers
UHT
Exchange
NYSE
SIC code
6798 Real Estate Investment Trusts
Sector
Real estate
Fiscal year ends
Dec 31
Incorporated in
MD
Filer category
Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:26 ET. Listed shows no prices and gives no investment advice.